Related Experiment Video
Updated: Dec 30, 2025

07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
19.1K
Between-tumor and within-tumor heterogeneity in invasive potential
Veena Padmanaban1, Yohannes Tsehay2, Kevin J Cheung1
1Center for Cell Dynamics and Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Plos Computational Biology
|January 22, 2020
Summary
Breast cancer metastasis, not primary tumor growth, causes death. New organoid methods reveal molecular drivers of metastasis, identifying Keratin 14 as a key invasion biomarker.
Area of Science:
- Oncology
- Genetics
- Biotechnology
Background:
- Breast cancer mortality is primarily driven by metastasis, which is challenging to study due to its complex, multi-year progression and the small fraction of cells involved.
- Within-tumor heterogeneity contributes to therapy failure and is often missed in bulk tissue analyses.
- Studying metastasis requires innovative approaches to capture cellular heterogeneity and track invasive processes.
Purpose of the Study:
- To exploit tumor heterogeneity for identifying molecular mechanisms of metastasis.
- To develop and validate novel statistical methods for analyzing organoid data to study metastasis.
- To identify molecular correlates of breast cancer invasion using patient-derived organoids.
Main Methods:
- Utilized patient-derived tumor organoids to model within-tumor heterogeneity.
- Developed population genetics and variance components models for statistical testing of organoid data.
- Quantified invasion phenotype using spectral power of organoid boundaries.
- Applied association tests to identify molecular markers linked to invasion.
Main Results:
- Organoids serve as reliable biological replicates, exhibiting similar within- and between-tumor variation.
- New statistical methods significantly amplify test power, with extreme phenotype organoids offering efficiency and cost savings.
- Identified a strong association between cancer cell invasion and Keratin 14 protein expression.
- Achieved highly significant p-values (p = 2 × 10-45 for within-tumor, p < 10-6 for pooled tests) for the invasion-Keratin 14 association.
Conclusions:
- Organoid-based approaches combined with advanced statistical methods offer powerful tools for studying metastasis.
- Keratin 14 is a significant molecular correlate of breast cancer invasion, potentially serving as a therapeutic target.
- These findings pave the way for discovering new cancer targets and developing novel therapeutics for metastasis.
Related Concept Videos
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K

